JP2024533993A5 - - Google Patents
Info
- Publication number
- JP2024533993A5 JP2024533993A5 JP2024508052A JP2024508052A JP2024533993A5 JP 2024533993 A5 JP2024533993 A5 JP 2024533993A5 JP 2024508052 A JP2024508052 A JP 2024508052A JP 2024508052 A JP2024508052 A JP 2024508052A JP 2024533993 A5 JP2024533993 A5 JP 2024533993A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- antigen
- binding fragment
- sequence
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110907583 | 2021-08-09 | ||
| CN202110907583.6 | 2021-08-09 | ||
| PCT/CN2022/111145 WO2023016450A1 (zh) | 2021-08-09 | 2022-08-09 | 抗tigit抗体及其用途 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024533993A JP2024533993A (ja) | 2024-09-18 |
| JP2024533993A5 true JP2024533993A5 (enExample) | 2024-09-26 |
Family
ID=85199833
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024508052A Pending JP2024533993A (ja) | 2021-08-09 | 2022-08-09 | 抗ｔｉｇｉｔ抗体およびその使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240352118A1 (enExample) |
| EP (1) | EP4386003A1 (enExample) |
| JP (1) | JP2024533993A (enExample) |
| KR (1) | KR20240043786A (enExample) |
| CN (1) | CN117794952A (enExample) |
| AU (1) | AU2022327511A1 (enExample) |
| CA (1) | CA3228504A1 (enExample) |
| WO (1) | WO2023016450A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116135884A (zh) * | 2021-11-17 | 2023-05-19 | 普米斯生物技术(珠海)有限公司 | 抗tigit-抗pd-l1双特异性抗体、其药物组合物及用途 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US8877688B2 (en) | 2007-09-14 | 2014-11-04 | Adimab, Llc | Rationally designed, synthetic antibody libraries and uses therefor |
| WO2009036379A2 (en) | 2007-09-14 | 2009-03-19 | Adimab, Inc. | Rationally designed, synthetic antibody libraries and uses therefor |
| MX381912B (es) | 2010-07-16 | 2025-03-13 | Adimab Llc | Colecciones de anticuerpos. |
| CN115925931A (zh) * | 2015-08-14 | 2023-04-07 | 默沙东公司 | 抗tigit抗体 |
| KR102585976B1 (ko) * | 2016-08-17 | 2023-10-05 | 컴퓨젠 엘티디. | 항-tigit 항체, 항-pvrig 항체 및 이들의 조합 |
| CA3042727A1 (en) * | 2016-11-19 | 2018-05-24 | Potenza Therapeutics, Inc. | Anti-gitr antigen-binding proteins and methods of use thereof |
| WO2018102746A1 (en) * | 2016-12-02 | 2018-06-07 | Rigel Pharmaceuticals, Inc. | Antigen binding molecules to tigit |
| CN111050788A (zh) * | 2017-02-28 | 2020-04-21 | 西雅图基因公司 | 抗tigit抗体 |
| IL272227B2 (en) * | 2017-07-27 | 2025-09-01 | iTeos Belgium SA | Anti-tigit antibodies |
| TWI754157B (zh) * | 2018-07-25 | 2022-02-01 | 大陸商信達生物製藥（蘇州）有限公司 | 抗ｔｉｇｉｔ抗體及其用途 |
| CN112794909B (zh) * | 2021-02-04 | 2022-06-14 | 广州爱思迈生物医药科技有限公司 | 一种抗tigit单克隆抗体及其应用 |
-
2022
- 2022-08-09 KR KR1020247007621A patent/KR20240043786A/ko active Pending
- 2022-08-09 US US18/682,325 patent/US20240352118A1/en active Pending
- 2022-08-09 JP JP2024508052A patent/JP2024533993A/ja active Pending
- 2022-08-09 WO PCT/CN2022/111145 patent/WO2023016450A1/zh not_active Ceased
- 2022-08-09 AU AU2022327511A patent/AU2022327511A1/en active Pending
- 2022-08-09 CA CA3228504A patent/CA3228504A1/en active Pending
- 2022-08-09 CN CN202280054124.0A patent/CN117794952A/zh active Pending
- 2022-08-09 EP EP22855431.7A patent/EP4386003A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7478222B2 (ja) | 抗ｃｄ３抗体及び該抗体を含む分子 | |
| US12497454B2 (en) | Anti-ROR1 antibodies and compositions | |
| US9709568B2 (en) | Antibodies that bind to human programmed death ligand 1 (PD-L1) | |
| JP2024045098A (ja) | 抗体－薬物コンジュゲートの薬物部位を認識する蛋白質 | |
| CN119350498A (zh) | 一种抗体及其用途 | |
| EP4403574A1 (en) | Protein specifically binding to pd-1 and pharmaceutical use thereof | |
| EP4039704A1 (en) | Anti-pd-1 antibody and use thereof | |
| US20180142032A1 (en) | Anti-lamp1 antibodies and antibody drug conjugates, and uses thereof | |
| JP2025514636A5 (enExample) | ||
| WO2023219147A1 (ja) | Ｃｃｒ８検出用新規抗ｃｃｒ８抗体 | |
| JP2023530766A (ja) | 二重特異性抗体及びその用途 | |
| JP2025512119A5 (enExample) | ||
| JP2024542944A5 (enExample) | ||
| JP2025505650A5 (enExample) | ||
| JP2025513930A5 (enExample) | ||
| US20200400675A1 (en) | Progastrin as a biomarker for immunotherapy | |
| WO2022242663A1 (en) | Anti-tigit antibodies and their use | |
| JP2024508597A5 (enExample) | ||
| CN120718149B (zh) | Pd-1抗体及其应用 | |
| WO2025261432A1 (en) | Anti-cdcp1 antibodies and uses thereof | |
| WO2025207653A1 (en) | Antibodies against lilrb4 and lilrb2 and uses thereof | |
| RU2790326C2 (ru) | Анти-сd3-антитело и молекула, содержащая это антитело | |
| CN121464158A (zh) | 抗Claudin18.2抗体及其制备和使用方法 | |
| RU2025105360A (ru) | Связывание антител с рецептором тиреотропного гормона и их применение | |
| WO2025230866A1 (en) | Anti-alpha5 integrin antibodies and uses thereof |